mechanism 1,343 words KG: ent-gene-83d99ff1 2026-04-01
kind:mechanismsection:mechanismsstate:published
Contents

FUS Proteinopathy Pathway in ALS

🔬 Protein Info
Gene Symbolent-gene-83d99ff1
Chromosome16p11.2.
Function- Reduced mitochondrial transport along axons
N-terminal low-complexity domain (LCD)intrinsically disordered region prone to phase separation
RNA recognition motif (RRM)binds RNA molecules
Multiple zinc finger motifsnucleic acid binding
C-terminal proline-rich regionprotein-protein interactions
Transcription regulationmodulates gene expression through interaction with transcription factors
Alternative splicinginfluences splice site selection
RNA transportfacilitates mRNA trafficking
DNA damage responseinvolved in repair mechanisms
Earlier disease onsetmean age 44 years vs. 56 years for sporadic ALS
Rapid progressionmedian survival 20-30 months from symptom onset
Bulbar onset more commonapproximately 40% of cases
Prominent cognitive involvementup to 30% develop FTD
Less prominent pseudobulbar affectcompared to SOD1-ALS
KG Connections2 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (22)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Vagal Afferent Microbial Signal Modulation
Score: 0.52
Transcriptional Autophagy-Lysosome Coupling
Score: 0.66
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.51

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed

Related Experiments (22)

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40

Knowledge Graph (2 edges)

ent-gene-83d99ff1 data_in benchmark_ot_ad_answer_key:FUS
benchmark_ot_ad_answer_key:FUS data_in ent-gene-83d99ff1